SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 22nd, 2022 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 22, 2022, between Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.Salarius Pharmaceuticals, Inc. • April 22nd, 2022 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 26, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 26, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
VOTING AGREEMENTVoting Agreement • April 22nd, 2022 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Voting Agreement (this “Voting Agreement”), dated April 25, 2022, is being delivered to you in connection with an understanding by and between Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
